Butterfly Network (BFLY) Stock Forecast & Price Target

Butterfly Network is compelling because its cMUT-based Ultrasound-on-Chip platform delivers whole-body imaging from a handheld probe at lower cost than traditional cart systems, supporting share gains in point-of-care ultrasound. Its growth outlook is strengthened by a more diverse monetization engine: Butterfly Embedded has 12 partnerships and already reached 33% of total sales in 2Q26, while Garden applications could add about 8% to 2027 growth. With gross margin improving to the mid-60%s in 2025 and management targeting more than $550 million in annual revenue over time, the combination of innovation, licensing, and operating leverage supports a positive fundamental view.

Butterfly Network is a growth story that may face multiple contraction as it begins to lap tougher comps in 2H26, especially if revenue dollars or growth disappoint versus expectations. Management’s 2026 revenue guidance of $119-123 million implies investors are already pricing in strong execution, yet the company’s value still depends heavily on longer-term Embedded projects and the Midjourney partnership, which could become a larger comparison headwind beginning in 4Q26. At the same time, the business faces competitive, regulatory, reimbursement, supplier, pricing, and customer concentration risks, leaving limited margin for error if near-term growth slows.